Seroprevalence of viral hepatitis B and C in two populations: blood donors and patients with suspected hepatic cirrhosis in Kwilu province, Democratic Republic of Congo
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are associated with high morbidity and mortality in the developing world due to the risk of developing cirrhosis, liver failure, hepatocellular carcinoma, and death (McMahon, 2009). According to the Global Hepatitis Report by the World Health Organization (WHO) in 2015, an estimated 257 million people worldwide were infected with HBV and 71 million people with HCV, causing about 1.34 million deaths annually (The Lancet GBD 2017, 2018).
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Junior Mudji, Justice Malala, Yves Horsmans Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Congo Health | Hepatitis | Hepatitis B | Hepatitis C | Hepatocellular Carcinoma | Infectious Diseases | International Medicine & Public Health | Liver | Liver Cancer | Urology & Nephrology | WHO